Dr. Peter I. Lobo, MD

Dr. Lobo practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Lobo's NPI, 1942345871, was assigned on February 20, 2007. Dr. Lobo holds Virginia license 0101025584.

Dr. Lobo's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Lobo's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Lobo is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Lobo to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lobo practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lobo's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lobo is licensed in Virginia.

CMS data shows 490 Medicare services from Dr. Lobo across 9 procedure codes in 2024, for 216 Medicare patients. Medicare paid $33,173 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 216 Medicare patients who saw Dr. Lobo in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 3.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lobo's median patient age at 64, with 49% women.

In 2024, Dr. Lobo wrote 519 Medicare Part D claims for 69 patients. 96% of them were for generic drugs. CMS names the drug for 400 of them, across 13 drugs with 11 or more claims each, at $13,047 in total drug cost. In 2023, CMS named 455 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Lobo for performance year 2024, reported as part of a group. Dr. Lobo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Lobo, published from 2002 to 2023. 2012 was the busiest year, with 4. The most frequent topics are Immunoglobulin M, Autoantibodies and Inflammation. Dr. Lobo has published most often in J Immunol. Dr. Lobo's most frequent co-authors are Mark D. Okusa, MD, Amandeep Kaur Bajwa, MD and Kenneth L. Brayman, MD.

CMS Open Payments shows 1 general payment to Dr. Lobo from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $96.